Orb Therapeutics Inc.
PrivateLast Round
Grant
Jul 15, 2025
Total Funding Raised
$100,000
Company Overview
Orb Therapeutics Inc. operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was an Accelerator round in June 2025.
Orb Therapeutics Inc. is a biotechnology company that develops RNA-based therapies to treat a range of genetic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orb Therapeutics Inc. Comparables
Compare Orb Therapeutics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Replicate Bioscience | 83% | |
| City Therapeutics | 82% | |
| Tevard Biosciences | 82% |
For institutional investors. Book with your work email.
Orb Therapeutics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 15, 2025 | ||||
| Accelerator | Jun 11, 2025 | ||||
| Grant | Jun 9, 2025 |
For institutional investors. Book with your work email.
Orb Therapeutics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Northpond Ventures | Accelerator |
| McKesson Ventures | Accelerator |
| National Research Council of Canada | Grant |
| New Jersey Innovation Institute | Accelerator |
| Ontario Centre of Innovation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 15, 2025
$54K grant received from National Research Council of Canada.
- Jun 11, 2025
$100K round with Merck, Northpond, and McKesson Ventures.
For institutional investors. Book with your work email.
Orb Therapeutics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Orb Therapeutics Inc.'s valuation, stock price, and market status.
Is Orb Therapeutics Inc. a public or private company?
Orb Therapeutics Inc. is a private company.
What is the current stock price of Orb Therapeutics Inc.?
Orb Therapeutics Inc. is a private company, so its shares have no public market price. Caplight tracks Orb Therapeutics Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Orb Therapeutics Inc. worth (valuation)?
Valuation information for Orb Therapeutics Inc. is not publicly available.
Can I buy Orb Therapeutics Inc. stock?
Orb Therapeutics Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Orb Therapeutics Inc.'s last funding round?
Orb Therapeutics Inc.'s most recent funding round was Grant on July 15, 2025.
Who are the main investors in Orb Therapeutics Inc.?
Key investors in Orb Therapeutics Inc. include Northpond Ventures, McKesson Ventures, National Research Council of Canada, New Jersey Innovation Institute, Ontario Centre of Innovation.
Will Orb Therapeutics Inc. IPO soon?
No public IPO plans have been announced for Orb Therapeutics Inc..
How can I track Orb Therapeutics Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Orb Therapeutics Inc.'s shares on secondary markets.